Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale CEO sold 3,928 shares at $23.80 ($93,486)
  2. 4 Open-market sale EVP, COO, Head of Commercial sold 538 shares at $23.05 ($12,401)
  3. 4 Open-market sale EVP & General Counsel sold 574 shares at $23.05 ($13,231)
  4. 4 Open-market sale President sold 1,937 shares at $23.05 ($44,648)
  5. 4 Open-market sale CEO sold 3,718 shares at $23.05 ($85,700)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale President sold 2,803 shares at $19.01 ($53,285)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale President sold 1,338 shares at $17.41 ($23,295)
  12. 4 Open-market sale CEO sold 2,963 shares at $17.41 ($51,586)
  13. 4 Option exercise Director acquired 1,918 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 25,564 shares (grant or award)
  20. 4 Open-market sale EVP and CFO sold 1,032 shares at $20.33 ($20,981)

Page 10 of 35 · 686 filings